Showing 2,681 - 2,700 results of 12,750 for search '"therapeutics"', query time: 0.06s Refine Results
  1. 2681

    Mechanism of connexin channel inhibition by mefloquine and 2-aminoethoxydiphenyl borate. by Pia Lavriha, Yufei Han, Xinyue Ding, Dina Schuster, Chao Qi, Anand Vaithia, Paola Picotti, Volodymyr M Korkhov

    Published 2024-01-01
    “…Connexin GJCs have emerged as drug targets, with small molecule connexin inhibitors considered a viable therapeutic strategy in several diseases. The molecular mechanisms of GJC inhibition by known small molecule connexin inhibitors remain unknown, preventing the development of more potent and connexin-specific therapeutics. …”
    Get full text
    Article
  2. 2682

    Pharmacological Evaluation of the SCID T Cell Transfer Model of Colitis: As a Model of Crohn's Disease by Thomas Lindebo Holm, Steen Seier Poulsen, Helle Markholst, Stine Reedtz-Runge

    Published 2012-01-01
    “…The finding that some well-established IBD therapeutics do not have any effect in the model highlights important differences between the experimental model and the human disease.…”
    Get full text
    Article
  3. 2683

    Telomere Biology: Key to unlocking the fountain of youth…A Systematic Review. by Anirban Poddar, Anup Kumar Rana, Ranjita Santra, Phalguni Chakrabarti

    Published 2024-11-01
    “…As the role of telomere biology is well established in ageing,current research therefore aims to develop means to reduce telomere attrition,thereby reducing ageing & age related diseases.This review will focus on summarising the role of telomere biology in ageing & age related diseases while highlighting the recent advances in research aiming towards enhanced longevity & healthy ageing.This review will further emphasize on telomere targetted therapeutics such as telomerase activators & tankyrase inhibitors while also highlighting the role of antioxidative & antiinflammatory agents alongwith indirectly related approaches such as statins.…”
    Get full text
    Article
  4. 2684

    Bone-Targeted Therapies in Metastatic Castration-Resistant Prostate Cancer: Evolving Paradigms by Joelle El-Amm, Ashley Freeman, Nihar Patel, Jeanny B. Aragon-Ching

    Published 2013-01-01
    “…Other novel bone-targeted agents are currently in development, including the receptor tyrosine kinase inhibitors cabozantinib and dasatinib. Emerging therapeutics in mCRPC has resulted in great strides in preventing one of the most significant sources of complications of bone metastases.…”
    Get full text
    Article
  5. 2685

    Cellulose Based Nano-Scaffolds for Targeted Cancer Therapies: Current Status and Future Perspective by Li Y, Liu W, Wang Y, Lu S

    Published 2025-01-01
    “…Their possibilities as a tool to overcome the limitations of conventional cancer therapeutics are also discussed. We also explore future directions for improving the efficacy of cellulose based carriers in cancer therapy.Keywords: cellulose – nanocarriers, cellulose scaffold, cellulose based cancer therapy, biomedical applications…”
    Get full text
    Article
  6. 2686

    Establishing endotoxin limits to enhance the reliability of in vitro immunogenicity risk assessments by Yun Hee Jeong, Gillian Lennon, Geertruida Veldman, Daniel M. Serna, Alexander Ibrahimov

    Published 2025-12-01
    “…To mitigate ADA risks, in vitro risk assessment assays in non-clinical settings are essential to enhance safety and efficacy of protein-based therapeutics. This study aimed to develop and validate a human in vitro immunogenicity T cell proliferation assay. …”
    Get full text
    Article
  7. 2687
  8. 2688

    Martini compatible coarse-grained model of polyethylenimine for pulmonary gene delivery by Graham Lunt, Niloofar Hashemi, Subhamoy Mahajan, Tian Tang

    Published 2025-02-01
    “…Abstract Pulmonary gene delivery has demonstrated high specificity for respiratory diseases, offering great control on dosage of therapeutics and side effects. On the other hand, intrinsic barriers in pulmonary systems impose new challenges such as crossing the pulmonary surfactant and evading mucus entrapment. …”
    Get full text
    Article
  9. 2689

    Discovery of potent allosteric antibodies inhibiting EGFR by Léxane Fournier, Lukas Pekar, Birgitta Leuthner, Harald Kolmar, Lars Toleikis, Stefan Becker

    Published 2024-12-01
    “…Our results suggest that allosteric antibodies may be potential new modalities for therapeutics.…”
    Get full text
    Article
  10. 2690
  11. 2691

    Comparison of transcriptomic profiles between intracellular and extracellular Bartonella henselae by Shiva Kumar Goud Gadila, John R. Caskey, Edward B. Breitschwerdt, Ricardo G. Maggi, Monica E. Embers

    Published 2025-01-01
    “…The development of novel therapeutics will benefit from the ability to determine target expression by Bartonella in relevant microenvironments.…”
    Get full text
    Article
  12. 2692
  13. 2693

    Unveiling Cathepsin B inhibition with repurposed drugs for anticancer and anti-Alzheimer's drug discovery. by Mohammed Alrouji, Sabina Yasmin, Mohammed S Alshammari, Fahad A Alhumaydhi, Sharaf E Sharaf, Moyad Shahwan, Anas Shamsi

    Published 2024-01-01
    “…Taken together, the findings suggest that Lurasidone and Paliperidone can act as repurposed CatB inhibitors with potential applications in the development of therapeutics against AD and other CatB-associated diseases after further validation.…”
    Get full text
    Article
  14. 2694

    Humatch - fast, gene-specific joint humanisation of antibody heavy and light chains by Lewis Chinery, Jeliazko R. Jeliazkov, Charlotte M. Deane

    Published 2024-12-01
    “…However, the majority of antibody therapeutics are not genetically human, with initial therapeutic designs typically obtained from animal models. …”
    Get full text
    Article
  15. 2695

    Equine Infectious Anemia Virus Cellular Partners Along the Viral Cycle by Cécile Schimmich, Astrid Vabret, Stéphan Zientara, José Carlos Valle-Casuso

    Published 2024-12-01
    “…A comprehensive vision of the interactions between the virus and specific host’s proteins can help with the discovery of new targets for the design of therapeutics. Studies performed on HIV-1 can provide insights into the functioning of EIAV, as well as differences, as both types of virus research can benefit from each other.…”
    Get full text
    Article
  16. 2696

    Vascularization, Innervation, and Inflammation: Pathways Connecting the Heart–Brain Axis and Implications in a Clinical Setting by Alexa R. Lauinger, Joseph J. Sepe

    Published 2025-01-01
    “…Through understanding the connection between these two organs, we can help inform patients and physicians of novel therapeutics for these pathologies.…”
    Get full text
    Article
  17. 2697

    Tumor-initiating and metastasis-initiating cells of clear-cell renal cell carcinoma by Dinh-Xuan Pham, Tien Hsu

    Published 2025-02-01
    “…Therefore new strategy for early diagnosis and therapeutics for this disease is urgently needed. The discovery of cancer stem cells (CSCs) offers hope for early cancer detection and treatment. …”
    Get full text
    Article
  18. 2698

    The Pivotal Role of TBK1 in Inflammatory Responses Mediated by Macrophages by Tao Yu, Young-Su Yi, Yanyan Yang, Jueun Oh, Deok Jeong, Jae Youl Cho

    Published 2012-01-01
    “…Even though relatively few studies have addressed the functional roles of TBK1 relating to inflammation, this paper discusses some recent findings that support the critical role of TBK1 in inflammatory diseases and underlie the necessity of trials to develop useful remedies or therapeutics that target TBK1 for the treatment of inflammatory diseases.…”
    Get full text
    Article
  19. 2699

    Probiotics for the Control of Parasites: An Overview by Marie-Agnès Travers, Isabelle Florent, Linda Kohl, Philippe Grellier

    Published 2011-01-01
    “…But more unravelling studies are needed to justify probiotic utilisation in therapeutics.…”
    Get full text
    Article
  20. 2700

    Adipose Tissue-Derived Stem Cells Alleviate Cold Allodynia in a Rat Spinal Nerve Ligation Model of Neuropathic Pain by Hyeon Seok Jwa, Yong Ho Kim, Jaehee Lee, Seung-Keun Back, Chul-Kyu Park

    Published 2020-01-01
    “…Neuropathic pain caused by lesions or nervous system dysfunction is a neuroimmune disease with limited therapeutic options. Adipose tissue-derived stem cells (ASCs) are multipotent mesenchymal stem cells with potent immunosuppressive properties, and their use as novel cell-based therapeutics have been proposed in many immune diseases. …”
    Get full text
    Article